Aptose Biosciences establishes new at-the-market facility
Aptose Biosciences announced it has entered into an “at-the-market” sales agreement with Piper Jaffray and Canaccord Genuity. This ATM replaces the previous ATM that the Company entered into with Cantor Fitzgerald in 2018. May 24, 2019